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Leukocyte Bim deficiency does 
not impact atherogenesis in 
ldlr−/− mice, despite a pronounced 
induction of autoimmune 
inflammation
Lieve Temmerman1, Marijke M. Westra2, Ilze Bot  2, Bart J. M. van Vlijmen3, Niek Van Bree1, 
Martine Bot2, Kim L. L. Habets2, Tom G. H. Keulers4, Johan van der Vlag  5, Thomas G. 
Cotter6, Theo J. C. van Berkel2 & Erik A. L. Biessen1,7
Proapoptotic Bcl-2 family member Bim is particularly relevant for deletion of autoreactive and 
activated T and B cells, implicating Bim in autoimmunity. As atherosclerosis is a chronic inflammatory 
process with features of autoimmune disease, we investigated the impact of hematopoietic Bim 
deficiency on plaque formation and parameters of plaque stability. Bim−/− or wild type bone marrow 
transplanted ldlr−/− mice were fed a Western type diet (WTD) for 5 or 10 weeks, after which they were 
immunophenotyped and atherosclerotic lesions were analyzed. Bim−/− transplanted mice displayed 
splenomegaly and overt lymphocytosis. CD4+ and CD8+ T cells were more activated (increased CD69 
and CD71 expression, increased interferon gamma production). B cells were elevated by 147%, with 
a shift towards the pro-atherogenic IgG-producing B2 cell phenotype, resulting in a doubling of anti-
oxLDL IgG1 antibody titers in serum of bim−/− mice. Bim−/− mice displayed massive intraplaque 
accumulation of Ig complexes and of lesional T cells, although this did not translate in changes in 
plaque size or stability features (apoptotic cell and macrophage content). The surprising lack in plaque 
phenotype despite the profound pro-atherogenic immune effects may be attributable to the sharp 
reduction of serum cholesterol levels in WTD fed bim−/− mice.
Atherosclerosis is a chronic inflammatory disease of the large vessels characterized by lipid accumulation in 
the intimal wall1. Oxidized low density lipoprotein (LDL) functions as an autoantigen2, and a “vascular autoim-
munosome” has recently been identified stressing the importance of autoimmunity in vascular injury and plaque 
development3. As the disease progresses, apoptosis in the vascular wall gradually increases4. In early atherogenesis 
apoptosis is regarded to be a beneficial factor as it dampens plaque inflammation and limits lesion expansion5, 6. 
At later stages of atherosclerosis however, clearance of apoptotic cells is insufficient7, and the ensuing secondary 
necrosis may here promote necrotic core formation and inflammation, both hallmarks of plaque destabilization.
The Bcl-2 family of pro- and anti-apoptotic proteins regulates apoptosis induced by cellular stressors such 
as DNA damage, UV radiation and oxidative stres8. Proteins of this family share one to four Bcl-2 homology 
(BH) domains8. In vivo studies in atherosclerotic mouse models have established a role for various Bcl-2 family 
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members in apoptosis of atherosclerotic lesion macrophages9, 10. Bim (Bcl-2 interacting mediator of cell death) is a 
BH3-only pro-apoptotic protein of the Bcl-2 family11, 12 and, like other BH3-only proteins, binds to anti-apoptotic 
Bcl-2 family members thereby initiating apoptosis13. Studies in Bim deficient mice have revealed crucial func-
tions of Bim in leukocyte homeostasis. Bim deficient granulocytes and lymphocytes are less sensitive to apoptosis 
induced by cytokine deprivation or various pro-apoptotic stimuli14, 15. Moreover, Bim deficient mice display leu-
kocytosis, with markedly elevated B and T cell numbers in circulation, spleen and thymus, and more circulating 
monocytes and granulocytes14. Bim was seen to be necessary for appropriate control and termination of immune 
responses16 and accordingly, its deficiency resulted in autoimmunity and lymphadenopathy due to defective 
removal of autoreactive T and B cells14, 17, 18.
Given its critical function in leukocyte homeostasis and autoimmunity control, a role for this protein in the 
pathogenesis of atherosclerosis is anticipated. Therefore, in the present study we have investigated the role of Bim 
regulated leukocyte apoptosis in atherosclerosis-prone ldlr−/− mice. Our study shows that hematopoietic Bim 
deficiency in ldlr−/− mice results in increased atherosclerotic lesion T cell content and massive immunoglobulin 
deposition as well as increased circulating T and B cells and high levels of anti-oxidized LDL autoantibodies. 
Furthermore, we demonstrate that loss of leukocyte Bim interferes with lipid metabolism.
Results
Bim−/− BM transplanted mice have splenomegaly and increased levels of circulating lympho-
cytes. The role of leukocyte Bim expression in atherogenesis was studied in chimeras generated by transplant-
ing bone marrow (BM) from bim−/− and wt littermates to irradiated ldr−/− recipients. After recovery, all mice 
were fed a Western-type diet containing 0.25% cholesterol (WTD) for 5 (initial atherogenesis) or 10 (advanced 
atherosclerosis) weeks (Fig. 1a). Wt and bim−/− chimeric mice (from here on wt and bim−/− mice) showed pro-
gressive but equivalent weight gain (Fig. 1b). After 5 weeks of WTD, neutrophil counts in spleen as well as in cir-
culation, were unaffected by the loss of Bim (Sup. Fig. 1). While circulating monocyte numbers were unaffected, 
those of spleen were slightly reduced in bim−/− mice. Furthermore both in spleen and in blood we observed a shift 
towards non-classical “inflammatory” Ly6Clow monocytes, compatible with dampened WTD associated Ly6Chigh 
monocytosis (Sup. Fig. 1). Both at 5 and at 10 weeks of WTD however, bim−/− mice suffered from splenomegaly 
(1.8 fold increase in relative weight, Fig. 1c) and leukocytosis (Fig. 1d). The latter was attributable to expansion of 
total T cells - both CD4+ and CD8+ - and B cells in blood of the bim−/− mice (Fig. 1d).
Apoptotic cell death is affected by loss of leukocyte Bim. 24 hours before sacrifice, mice were 
injected with BrdU, and we evaluated BrdU incorporation in splenocytes by flow cytometry. The Bim defi-
ciency associated splenomegaly could not be explained by increased proliferation, as there were no differences 
between wt and bim−/− mice in BrdU-positive T and B cells (Fig. 2a,b). However, apoptotic cell content in 
bim−/− spleens in vivo was significantly lower than in wt spleens (1.8 ± 0.3 vs. 3.3 ± 0.4% of total splenocytes 
Figure 1. Bim−/− chimeric mice have splenomegaly and lymphocytosis. (a) Lethally irradiated ldlr−/− mice 
were reconstituted with wt or bim−/− bone marrow, and after 6 weeks recovery, put on a Western Type Diet 
containing 0.25% cholesterol for 5 (n = 7) or 10 weeks (n = 12). (b) Body weight of wt and bim−/− chimeric 
mice. Data is presented as mean ± SEM. ***p < 0.001 in two-way ANOVA. (c) Relative spleen weight of wt 
and bim−/− chimeric mice at sacrifice. Data is presented as mean ± SEM. ***p < 0.001 in two-way ANOVA. 
(d) TruCount tubes were used for quantitative analysis of leukocyte subsets in blood of wt and bim−/− chimeric 
mice after 5 weeks of WTD. Data is presented as mean ± SEM. p < 0.001 between wt and bim−/− groups in two-
way ANOVA.
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respectively, p < 0.01, Fig. 2c). Bim’s proapoptotic activity was further confirmed in bim−/− bone marrow derived 
macrophages (BMDM), which showed decreased sensitivity to apoptotic cell death at baseline, and in response 
to known proapoptotic stimuli (i.e. growth factor withdrawal and oxidized LDL) (Fig. 2d). Taken together, these 
data clearly demonstrate that changes in leukocyte numbers in bim−/− atherosclerotic mice are a consequence of 
increased cell survival due to the loss of pro-apoptotic Bim.
Loss of Bim favors a Th1 cytolytic immune profile. Related to Bim’s role in lymphocyte cell survival, 
it has also been associated with autoimmunity14. We therefore evaluated the consequences of hematopoietic Bim 
deficiency on adaptive immune cells. CD4+ and CD8+ T cell subsets were found to be more activated in bim−/− 
mice in comparison with wt mice as judged from the enhanced expression of activation markers CD69 and 
CD71 (p < 0.05, Fig. 3a,b). In addition, while all T cell subsets increased in absolute numbers, the deletion of Bim 
resulted in a clear shift towards more CD8+ T cells (Fig. 3c). Moreover T cell polarization was skewed towards 
Th1, as evidenced by a higher proportion of Tbet+ CD4+ T cells in blood of bim−/− mice as well as a higher 
production of IFNγ by CD4+ T cells in response to ex vivo PMA stimulation (Fig. 3d,e,f). Contrarily, wt and 
bim−/− PMA-stimulated CD4+ T cells did not show differences in IL4 production (Sup. Fig. 2a,b) and regulatory 
T cells were unaffected by loss of Bim (Fig. 3g,h). In addition, we sorted CD4+ T cells from wt and bim−/− chi-
meric mice. Pure, sorted CD4+ T cells from wt and bim−/− mice after 5 weeks on WTD were in vitro stimulated 
with PMA/ionomycin and expression levels of IL-10, IL-17, IFNγ and TNFα were measured by real-time PCR. 
Bim−/− derived CD4+ T cells tended to show higher IFNγ expression, confirming our intracellular expression 
Figure 2. Bim−/− leukocytes are more resistant towards apoptosis. (a,b) After 5 weeks of WTD, wt and bim−/− 
chimeric mice were injected with BrdU 24 and 12 hrs before sacrifice to quantify proliferating cells. BrdU 
incorporation in T (a) and B (b) cell subsets was measured by flow cytometry. Mean ± SEM are indicated. (c) 
Cyrosections of wt and bim−/− spleens after 10 weeks of WTD were analyzed by TUNEL staining to quantify 
apoptotic cells (n = 8 for wt, n = 10 for bim−/−). Data is presented as mean ± SEM. **p < 0.01 in student’s t 
Test. (d) wt and bim−/− bone marrow derived macrophages (n = 5) were exposed to different apoptotic stimuli 
(growth factor withdrawal or oxLDL 40 μg/ml) and percentage of apoptotic cells was quantified by flow 
cytometry based on AnnexinV and Propidium Iodide signals. Body weight of wt and bim−/− chimeric mice. 
Data is presented as mean ± SEM. *p < 0.05, **p < 0.01 in Mann-Whitney U Test.
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data. IL-10 expression was unchanged, and TNFα as well as IL-17 expression were undetectable in both wt and 
bim−/− derived CD4+ T cells (Sup. Fig. 2c–e). Bim deficiency in atherosclerotic mice thus creates a more Th1/
CD8+ oriented cellular T cell response without significantly altering other T cell reponses.
Leukocyte Bim deficiency affects the humoral immune response in ldlr−/− mice. Apart from its 
impact on T cell homeostasis, loss of Bim was reported to be associated with impaired deletion of autoreactive 
B cells. The resulting accumulation of these cells and derived autoreactive antibodies in vivo can promote auto-
immunity18. An important indicator that autoimmune processes are involved is the appearance of anti-dsDNA 
autoantibodies in the blood, which were indeed observed in bim−/− mice and increased upon WTD feeding 
(Fig. 4a,b). Moreover, bim−/− mice showed a marked expansion of the B2 subset in blood and spleen (Fig. 4c). 
This was not the case for circulating B1 cells, while splenic B1 cells were also increased, but to a much lower 
Figure 3. Bim−/− T cells are more activated. (a,b) After 10 weeks of WTD, CD69 and CD71 expression on 
CD4+ and CD8+ T cells, respectively, were quantified by flow cytometry (n = 12). (c) The CD4+/CD8+ T cell 
ratio is disturbed in bim−/− chimeric mice. Flow cytometry measurements on blood after 5 weeks of WTD 
(n = 7). (d) Bim−/− chimeric mice have more Tbet+ CD4+ T cells. TruCount flow cytometry measurements 
after 5 weeks of WTD (n = 7). (e) Wt and bim−/− splenocytes were harvested after 5 weeks of WTD, stimulated 
in vitro with PMA and ionomycin and IFNγ production in T cells was quantified using flow cytometry (n = 7). 
(f) Gatings for the IFNγ positive cells quantified in (e). (g) Regulatory T cell populations are similar between 
bim−/− and wt chimeric mice. Flow cytometry measurements on bone marrow after 5 weeks of WTD (n = 7). 
(h) Gatings for the FoxP3+ Treg cells cells quantified in (g). Data is presented as mean ± SEM. *p < 0.05, 
**p < 0.01, ***p < 0.001 in Mann-Whitney U Tests.
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extend than the B2 cell population. B2 cells are responsible for the production of antigen-specific IgG antibodies. 
OxLDL is an established autoantigen in atherosclerosis and IgG type anti-OxLDL autoantibodies are considered 
pro-atherogenic19, 20. We therefore measured OxLDL directed autoantibody titers in serum after 10 weeks of 
WTD. IgG1 and IgG2b anti-OxLDL antibodies were increased by more than two-fold (p < 0.05, Fig. 4d) in bim−/− 
mice compared to controls; no differences were detected in IgM and IgG2a anti-OxLDL autoantibody titers.
Atherosclerotic lesions in bim−/− mice are hallmarked by T cell infiltration and immunoglobu-
lin deposits. The pronounced Th1 shift, combined with the increase in IgG autoantibodies, effects that both 
are considered pro-atherogenic, led us to expect a more severe plaque phenotype in bim−/− chimeras. Much to 
our surprise, we did not observe any significant differences in lesion size in aortic root between groups at ather-
osclerosis onset (5 weeks WTD) or in more advanced plaques (10 weeks WTD) (Fig. 5a top and bottom panels 
respectively); if anything plaques even tended to be smaller. In agreement, en face analysis of the descending 
aorta after 10 weeks of WTD showed no differences in atherosclerotic lesion area as well (Fig. 5a middle panels). 
Regarding composition, lesional MOMA-2 positive macrophage content in bim−/− did not differ from that in wt 
mice (Fig. 5b, top panels). Moreover, TUNEL staining of 10 weeks WTD aortic root sections as well as cleaved 
caspase 3 staining of 5 weeks WTD aortic root sections revealed no differences in lesional apoptotic cell content 
between wt and bim−/− mice (Sup. Fig. 3a,b).
As this was a somewhat surprising result, considering our earlier observed decreased sensitivity to apopto-
sis in spleen and in BMDMs, we assessed the functional profile of bim−/− macrophages. Hereto wt and bim−/− 
BMDMs were stimulated with LPS or IL4 to obtain M1- and M2-polarized macrophages respectively and gene 
expression was analyzed by real-time PCR. Apart from a slightly higher IL6 expression after LPS stimulation, 
other M1 cytokines (IL10, TNFα) and M2 cytokines (Mannose Receptor, Fizz1, YM1) did not change between 
wt and bim−/− BMDMs (Sup. Fig. 3c,d,e). Apoptotic content in the plaque is the resultant of the apoptosis rate 
(which could be reduced in bim−/− macrophages) and the capacity of plaque macrophages to efficiently clear away 
dead cells. Therefore, we analyzed efferocytosis in wt and bim−/− BMDMs. Bim−/− BMDMs appeared to be less 
effective in efferocytosis (p = 0.05; Sup. Fig. 3f,g).
In keeping with elevated T cell levels in circulation and lymphoid organs, T cell content in the atherosclerotic 
lesions (intima and adventitia) was increased by 51% from 10.1 ± 1.2 per section in wt mice to 15.3 ± 1.6 per 
Figure 4. Bim deficiency alters the humoral response in atherosclerotic mice. (a) After 5 weeks of WTD, anti-
dsDNA autoantibodies in sera of wt and bim−/− chimeric mice (n = 7) were quantified by ELISA. (b) Paired 
anti-dsDNA autoantibody determination in sera before start of WTD and after 5 weeks of WTD in 5 wt and 2 
bim−/− chimeric mice. 2-way ANOVA test shows highly significant effects of both the bim−/− phenotype as well 
as the induction of the diet (p < 0.0001). (c) B1 and B2 cells in the blood and spleen of wt or bim−/− chimeric 
mice after 5 weeks of WTD were defined as CD19+, CD220+, CD11b+ (B1) and CD19+, CD220+, CD5−, 
CD11b− (B2) respectively using flow cytometry (n = 7). (d) oxLDL specific antibody titers were measured by 
ELISA in sera of wt or bim−/− chimeric mice after 10 weeks of WTD (n = 12). Data is presented as mean ± SEM. 
*p < 0.05, **p < 0.01, ***p < 0.001.
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section in bim−/− mice (p < 0.05, Fig. 5b, middle panels). Importantly, staining for deposits of total immunoglob-
ulins (Ig) in lesions revealed the striking presence of Ig complexes in lesions of bim−/− chimeras but not littermate 
controls (0.10 ± 0.04% versus 1.08 ± 0.04%; p < 0.05, Fig. 4b, bottom panels). In summary, lesions in bim−/− ani-
mals did not differ in size or apoptotic cell content, although they demonstrated clear signs of increased cellular 
T cell as well as humoral (Ig complexes) immunity.
Loss of leukocyte Bim reduces high fat diet-induced hyperlipidemia. Intrigued by the surprising 
lack of effects of bim deficiency on atherogenesis despite the overall proatherogenic phenotype of bim−/− mice, 
we zoomed in on confounders which could have masked the overt autoimmune responses in these mice. Lipids, 
and LDL-cholesterol in particular, are crucial in creating the proinflammatory environment critical to the devel-
opment of atherosclerosis. After 10 weeks of WTD, we observed significantly reduced plasma levels of cholesterol 
and triglycerides (Fig. 6a). A role for (hematopoietic) leukocyte Bim in cholesterol homeostasis has not been 
described so far. This could be a consequence of an alerted autoimmune state interfering either at the level of 
cholesterol absorption in duodenum, or of its production by liver. However, body weights were unchanged, and 
pathological examination did not reveal any signs of autoimmune or inflammatory damage in duodena of wt 
and bim−/− chimeras, with both groups showing structurally intact villi (Fig. 6b). After 5 weeks of WTD, liver 
immune cell presence did not differ between bim−/− chimeras and controls either (Fig. 6c left panels and graph). 
At 10 weeks of WTD however, we noticed the overt presence of cellular infiltrates containing large amounts 
of T cells in livers of bim−/− but not wt mice (Fig. 6c, middle and right panels). Our data thus suggest that the 
pro-inflammatory effects of Bim deficiency are counteracted at least in part by lipid lowering, which may be due 
to progressive steatohepatitis compromising crucial lipid metabolic functions.
Discussion
Bim is essential for apoptosis of various leukocyte subsets, including T and B cells, dendritic cells, macrophages 
and granulocytes14, 15, 21. These cell types are all shown to be present in atherosclerotic lesions and to contribute 
to disease development. In addition, Bim specifically deletes autoreactive T and B cells18, 22, and atherosclero-
sis is a disease with clear autoimmune features23–25. Therefore, a role for Bim in lesional leukocyte apoptosis 
and (autoimmune-induced) atherogenesis may be anticipated. Here we show that hematopoietic Bim deficiency 
impacts on inflammatory status, an effect that is counteracted by an unexpected lowering of plasma cholesterol 
levels and a dampening of the WTD-induced monocytosis.
Absence of Bim decreased spontaneous apoptosis of bone marrow derived macrophages as well as apoptosis 
induced by growth factor withdrawal. These results are consistent with previous studies showing decreased apop-
tosis in Bim deficient T cells14, DCs21 and granulocytes15 in response to various stimuli. In addition we identify 
Bim as a regulator of OxLDL induced apoptosis of macrophages. However, while spleen apoptotic cell content 
was decreased in bim−/− mice as expected, we did not find any differences in apoptosis of atherosclerotic lesion 
cells, predominantly representing macrophages and foam cells. Given the scarce T-cell presence in atherosclerotic 
Figure 5. Plaques of bim−/− chimeras are marked by T cell accumulation and large Ig deposits. (a) 
Representative pictures of aortic root sections after 5 weeks and 10 weeks of WTD (top and bottom panel 
respectively), and descending aorta after 10 weeks of WTD (middle panel) reveal no differences in plaque 
size between wt and bim−/− chimeric mice. N = 7 (5 weeks WTD), n = 12 (10 weeks WTD). Data is shown as 
mean ± SEM. (b) Phenotypic analysis of atherosclerotic plaque composition in wt and bim−/− chimeric mice 
after 10 weeks of WTD (n = 12). Macrophage content was quantified by MOMA staining (top panel, blue), 
CD3 staining was used to identify T cells (middle panel, brown), and Ig complexes were visualized using FITC-
labeled anti-mouse Ig. Data is presented as mean ± SEM. *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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lesions26, apoptosis of this subset and hence Bim deficiency associated changes herein are not detectable. Further 
analysis into the functionality of bim−/− macrophages did not reveal striking changes in polarization, though 
we did observe a decrease in efferocytosis in bim−/− macrophages. One could speculate that the combination of 
increased survival of bim−/− (plaque – thus exposed to oxLDL and other pro-apoptotic stimuli) macrophages 
with their decreased efferocytosis capacity leads to a null-effect on overall plaque apoptosis. In addition, Ly6Chigh 
inflammatory monocytes were significantly reduced in bim−/− mice. Inflammatory monocytes are important 
contributors to plaque development and macrophage content27, and a lower influx of Ly6Chigh monocytes in 
bim−/− atheromas could further temper the pro-atherogenic WTD-induced phenotype.
The most profound consequences of Bim deficiency following BMT were observed on T cell homeostasis. 
Lymphocytes are importantly involved in regulating immune responses in atherosclerotic lesions26, 28. In keeping 
with previous studies14 we showed markedly elevated circulating lymphocyte levels and splenomegaly in bim−/− 
transplanted ldlr−/−. As suggested by Bouillet and Hildeman and colleagues lymphocytosis and splenomegaly 
may be caused by impaired apoptosis of leukocytes, in particular of autoreactive thymocytes and activated T 
cells, for which Bim has been demonstrated to be essential16, 17. In agreement with the latter, both CD4+ and 
CD8+ splenic T cells were more activated in bim−/− recipients than in control mice, and we observed a clear shift 
towards a Th1 immune profile. The elevated T cell numbers were also reflected in increased plaque T cell content 
indicating enhanced infiltration from circulation into the lesion. In addition to these effects on T cell immunity, 
Bim deficiency significantly raised B cell numbers, potentially modifying the humoral response in bim−/− mice. 
Taken together, our data shows that bim−/− leukocytes affect both components of the adaptive immune system 
in ldlr−/− mice.
Bim was previously reported to be necessary for apoptosis of autoreactive B cells18 and to prevent T-cell 
dependent autoimmunity14. Atherosclerosis is currently viewed as a lipid driven inflammatory process with fea-
tures of autoimmune disease24–26, implicating T cell responses to auto-antigens, such as oxLDL and heat shock 
proteins (HSP)25. In fact, oxLDL specific antibodies have been detected in atherosclerosis-prone ApoE−/− mice29, 
in human and rabbit serum and in atherosclerotic lesions30. Moreover, a subset of T cells present in human lesions 
was demonstrated to be oxLDL specific31. Concordant with Bim’s role in the control of autoreactive B cell forma-
tion, we observed markedly elevated oxLDL antibody levels in serum of bim−/− mice. In addition, total immuno-
globulin deposition in atherosclerotic lesions of bim−/− mice was dramatically increased. While previously B cells 
were considered to be atheroprotective32–35, more recent insights point however to divergent roles in atheroscle-
rosis36, 37. B2 cells, precursors of IgG producing plasma cells, are in fact proatherogenic38. The observed increase 
Figure 6. Lower cholesterol levels and liver infiltrates in bim−/− chimeric mice. (a) Cholesterol and Triglyceride 
levels in serum of wt and bim−/− chimeric mice after before (Basal) and after 10 weeks of WTD (Endpoint). 
N = 12. Mean + SEM are indicated. *p < 0.05, **p < 0.01 (b) Representative images of H&E stained wt and 
bim−/− duodena show intacρt villi. (c) Liver sections of wt and bim−/− chimeric mice were analyzed for 
leukocyte infiltration at 5 weeks WTD (brown CD45 staining on left panels, CD45+ cells encircled in red 
were quantified as is shown by the graph). After 10 weeks WTD, infiltrates are clearly visible on H&E stainings 
(middle panels, red circles) and contain high amounts of T cells (brown CD3 staining on right panels).
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in serum anti-oxLDL antibody titers in bim−/− mice in the present study is mainly due to elevated anti-oxLDL 
IgG1 levels, whereas anti-oxLDL natural antibody titers (IgM), elaborated by atheroprotective B1 cells, were not 
affected. This clearly points to an involvement of the proatherogenic B2 cell subset, which indeed was expanded 
in bim−/− mice. Anti-oxLDL IgG1 antibodies induce proinflammatory signaling upon binding to FcγRIII39, pro-
vided the activating FcγRIII receptors outnumber the inhibitory FcγRIIB molecules40. Inflammatory monocytes 
highly express FcγRIII, infiltrate the atherosclerotic plaque and become loaden with oxLDL, and are thus a likely 
target for the anti-oxLDL IgG1 antibodies in the bim−/− mice.
Despite marked effects on T cell levels and characteristics as well as on the humoral immune response, leuko-
cyte Bim deficiency in ldlr−/− mice did not alter plaque size or composition at an early as well as more advanced 
stage of disease development, apart from increased lesional T cell and immune complex accumulation. In con-
trast to our results, FcγRIIB−/− bone marrow transplanted ldlr−/− mice3 display a systemic autoreactive phe-
notype with splenomegaly, increased circulating autoantibodies and large lesional immunoglobulin complexes, 
accompanied by aggravated lesion development. Similarly to Bim deficient mice, the FcγRIIB−/− ldlr−/− chimeras 
showed reduced plasma cholesterol and TG levels3. Hence the discrepant outcomes of this study and ours is prob-
ably owing to the much stronger autoimmune phenotype of the FcγRIIB compared to the Bim deletion model. 
However, recent work by Ludwinksi et al. shows that Bim can trigger the activation of mature autoreactive T cells, 
through the calcium/NFAT pathway. This explains why Bim−/− bone marrow transplanted mice are protected 
against autoimmunity in an EAE and diabetes model41. Accordingly, activation of atherosclerotic antigen-specific 
T cells, having escaped thymic selection, might be compromised by the Bim deficiency in our model, explaining 
the mild plaque development. Moreover, the fact that two independent autoimmune models on a similar back-
ground (FcγRIIB −/− and Bim−/− on ldlr−/−) both lead to substantial decreases in serum lipids, suggests a shared 
molecular basis, linking autoimmunity to cholesterol metabolism. As we did not detect any structural damage 
to the villi of bim−/− duodena, it is unlikely that reduced intestinal cholesterol uptake is accountable for the Bim 
deficiency associated lipid lowering. In contrast, bim−/− livers displayed progressive leukocyte infiltrates highly 
enriched in T cells. Hepatocytes have the ability to prime naïve T cells, and the survival of liver-residing T cells 
is largely dependent on Bim42. The liver functions as a master regulator of cholesterol metabolism, and chronic 
steatohepatitis could conceivably lead to disturbances of lipid homeostasis in blood. Cholesterol homeostasis has 
already been linked to the chronic inflammatory status43, and in particular dendritic cell targeted interventions 
were repeatedly shown to alter plasma cholesterol levels44. It remains to be determined how hepatic T-cell inflam-
mation contributes to the attenuated hyperlipidemic response to Western Type Diet. Nevertheless, lower plasma 
lipid levels in bim−/− animals will undoubtedly contribute to a less atherogenic environment.
In conclusion, we show here that leukocyte Bim deficiency in ldlr−/− mice results in increased activated T-cell 
content in circulation, lymphoid organs and atherosclerotic lesions, in increased levels of autoreactive antibodies 
directed against oxidized LDL in circulation and in substantial immunoglobulin deposition in atherosclerotic 
lesions. Collectively however, these proatherogenic effects of leukocyte Bim deficiency are most likely counter-
balanced by a lowering of the Ly6Chigh monocytosis accompanied by a surprising reduction in serum lipid levels, 
leaving atherosclerosis development unaffected.
Methods
Animal work and bone marrow transplantation experiment. All animal work was approved by reg-
ulatory authority of Leiden and Maastricht and performed in compliance with the Dutch government guidelines. 
Pure C57Bl6 Ldlr−/− mice (backcrossed at least 10 generations) were obtained from the local animal breeding 
facility. C57Bl6 bim−/− mice for the 10 weeks WTD study were a kind gift from the Department of Biochemistry, 
Biosciences Research Institute, the University College Cork, Ireland and had been backcrossed at least 6 genera-
tions. For the 5 weeks WTD study, frozen pure C57Bl6 bim−/− (#JR 4525) and wt control bone marrow (#JR 664) 
was obtained from Jackson Laboratories, Maine. Male ldlr−/− mice (n = 38) were housed in sterile individual 
ventilated cages with food and water ad libitum. The drinking water was supplied with antibiotics (83 mg/l cip-
rofloxacin and 67 mg/l Polymixin B) and 5 g/l sugar. The mice were exposed to a single dose of 9 Gy total body 
irradiation (0.19 Gy/min, 200 kV, 4 mA) using an Andrex Smart 225 Röntgen source (YXLON International) one 
day before transplantation. Bone marrow was extracted from femurs and tibia of male bim−/− and wild-type (wt) 
littermates. Irradiated ldlr−/− mice received either 5 × 106 bim−/− bone marrow cells or 5 × 106 wt bone marrow 
cells via tail vein injection. After a recovery period of six weeks diet was changed from normal chow (RM3, 
Special Diet Services) to Western type diet (WTD) containing 0.25% cholesterol and 15% cacao butter (Diet W, 
Special Diet Services) for an additional five or ten weeks.
Blood cell analysis and flow cytometry. Blood samples were taken by tail bleeding before bone marrow 
transplantation (BMT) and before and after start of Western type diet feeding and at the time of sacrifice. Before 
start of the WTD, DNA was isolated from the blood tail vein sample using the Qiagen QIAamp® DNA Micro 
Kit according to manufacturer’s instructions. Chimerism was determined by quantitative real-time PCR using 
primers for LDLr (only present in the donor-derived cells, forward primer: 5′- GCT GCA ACT CAT CCA TAT 
GCA -3′, reverse primer: 5′- GGA GTT GTT GAC CTC GAC TCT AGA G -3′) and P50 (present in donor and 
recipient cells, forward primer: 5′- AAC CTG GGA ATA CTT CAT GTG ACT AA -3′, reverse primer: 5′ - GCA 
CCA GAA GTC CAG GAT TAT AGC -3′) and was 95,9% with a minimum of 88,5% for wt transplanted mice ver-
sus 96,3% with a minimum of 88,4% for bim−/− transplanted mice. Bim−/− genotype was confirmed by PCR using 
primers 5′-CATTCTCGTAAGTCCGAGTCT-3′ (forward), 5′-GTGCTAACTGAAACCAGATTAG-3′ (reverse, 
specific for wt allele) and 5′-CTCAGTCCATTCATCAACAG-3′(reverse, specific for deleted allele).
At sacrifice, mice were anesthesized and spleen was removed, gently dissociated through a 70 µm cell strainer 
(Greiner), treated with erylysis buffer (8.4 g NH4Cl, 0.84 g NaHCO3 in 1 l PBS) and stained for total leukocytes 
(CD45+, BioLegend), total T cells (CD3+, eBioscience), T helper cells (CD4+, BD Bioscience), cytotoxic T cells 
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(CD8α+, BD Bioscience), B cells (CD19+, eBioscience), B1 cells (CD5+, eBioscience), B2 cells (B220+, BD and 
CD5-, eBioscience), NK cells (CD3− NK1.1+, BD Bioscience) monocytes (CD11bhigh Ly6Glow, BD Bioscience) 
and neutrophils (CD11bhigh Ly6Ghigh, BD Bioscience). Activated T cells were stained with antibodies against 
CD69 and CD71 (eBioscience). IFNγ and IL4 producing T cells were quantified performing intracellular staining 
against IFNγ or IL4 (both eBioscience) after overnight PMA (50 ng/ml)/ionomycin (1 µg/ml) in vitro stimulation 
of isolated splenocytes. In vivo proliferation was assessed using the APC BrdU Flow kit (BD) according to the 
manufacturer’s instructions. Regulatory T cells were stained on bone marrow isolated at sacrifice after 5 weeks of 
WTD with FoxP3 intracellular staining kit (eBioscience) according to the manufacturer’s instructions. Absolute 
cell numbers in blood were calculated by use of Trucount tubes (BD). Absolute counts of other percentage-based 
in vivo flow cytometry plots throughout the paper are given in Sup. Fig. 4. All flow cytometry analysis was per-
formed on a BDCanto II (BD Bioscience) using FACS Diva Analysis Software vs6.
Tissue harvesting and analysis. Eleven (early atherogenesis, n = 7) or sixteen weeks (intermediate ath-
erogenesis, n = 12) after BMT, mice received intraperitoneal injections with BrdU 24 and 12 hrs before sacrifice 
(0.8 mg/mouse). Next day, mice were euthanized by i.p. administration of an overdose of pentobarbital (115 mg/
kg), blood was taken by left ventricular puncture, and mice were perfused with PBS after which heart, aorta, 
spleen, thymus, mediastinal lymph nodes, duodenum and liver were isolated and either further processed for 
flow cytometry, stored in 4% formaldehyde solution or snap-frozen in liquid nitrogen and stored at −80 °C. 
Cryosections were prepared of aortic valves, spleen and liver and stained with hematoxylin and eosin (HE) and/
or Oil Red ‘O. Paraffin sections were prepared of liver and duodena and stained with HE and for the presence 
of leukocytes (CD45, BD). The descending aorta was cut open longitudinally for en face analysis after staining 
with Oil Red ‘O. Immunohistochemistry was performed for macrophage (MOMA-2, Sigma) and T cell (CD3, 
Immunologic) content in aortic root lesion, liver and/or spleen sections. Apoptotic cell content after 5 weeks of 
WTD was quantified by cleaved caspase 3 staining (Cell Signaling). Apoptotic cell content after 10 weeks WTD 
was quantified using terminal deoxytransferase dUTP nick-end labeling (TUNEL) kit (Roche Diagnostics) and 
presence of immunoglobulins using FITC labeled rabbit anti-mouse Ig (DakoCytomation). Lesion size and tissue 
morphology was analyzed using Leica image analysis system, consisting of a Leica DMRE microscope with cam-
era and Leica Qwin Imaging software (Leica Ltd). Fluorescent immunohistochemistry was analyzed on a Nikon 
Eclipse E600 using ImagePro 4.5 software.
Detection of auto-antibodies by ELISA. Presence of anti-dsDNA autoantibodies was confirmed in col-
laboration with Dr. J. van der Vlag (Radboud University Medical Center, Nijmegen, Netherlands) using a peptide 
ELISA technique extensively described in Dieker et al.45. For quantification of anti-oxLDL autoantibodies, an 
EIA/RIA high binding 96-well plate (Corning) was coated with Ox-LDL (5 μg/ml) in a 50 mM Na2CO3/NaHCO3 
coating buffer (pH 9.6). IgM, IgG1 and IgG2a antibodies against Ox-LDL in serum were measured using an 
enzyme-linked immunosorbent assay (ELISA) Ig detection kit (Zymed Laboratories) according to the manufac-
turer’s protocol.
Macrophage apoptosis. Femurs and tibia were flushed with phosphate buffered saline (PBS) to isolate bone 
marrow. A single cell suspension was obtained by passing the bone marrow through a 70 µm nylon cell strainer 
(BD Falcon). Bone marrow cells were differentiated into macrophages by culturing in 70% RPMI, supplemented 
with 20% FCS, glutamine, pyruvate, penicillin/streptomycin and non-essential amino acids, and 30% M-CSF 
conditioned DMEM (obtained from L929 cells) for 7 days. Bone marrow derived macrophages (BMDM) were 
stimulated with 40 µg/ml ox-LDL, cultured without growth factors (30% M-CSF conditioned DMEM) or in con-
trol medium for 24 hours. The macrophages were detached with accutase (PAA Laboratories GmbH), stained 
with Annexin V (ImmunoTools) and propidium iodide (Sigma) and subsequently analyzed by flow cytometry 
using a FACSCalibur with CellQuest software (BD Biosciences).
Cholesterol and triglyceride levels. Blood samples were taken by tail bleeding before bone marrow 
transplantation (BMT) and before and after start of Western type diet feeding and at the time of sacrifice. Total 
cholesterol and triglyceride content was measured spectrophotometrically in serum using enzymatic procedures 
(Roche Diagnostics).
Real time PCR on sorted cells. Bone marrow was isolated by flushing femurs of wt and bim−/− mice 
after 5 weeks of WTD at sacrifice. Mature CD4+ T cells were present in both wt and bim−/− bone marrow in 
numbers consistent with literature46. CD4+ T cells were sorted as not dead, CD45+ (BioLegend), forward scatter 
low, CD19− (eBioscience), NK1.1− (BD Bioscience), Ly6G− (BD Bioscience) CD8α− (BD Bioscience), CD4+ 
(BD Bioscience). BMDM precursor cells were sorted as not dead, CD45+, forward scatter low, CD19−, NK1.1−, 
Ly6G−, CD8α− and CD4−, pooled together with not dead, CD45+, forward scatter high, CD19−, NK1.1−, Ly6G− 
and not dead, CD45+, CD19+, NK1.1+, Ly6G+ cells. Sorting was done on a BD Aria 1 machine. Sorted CD4+ T 
cells were in vitro stimulated with PMA (50 ng/ml)/ionomycin (1 µg/ml) overnight before lysis with TRIzol®. 
BMDM precursors were differentiated into macrophages as described above and stimulated for 3 hours with 
LPS (50 ng/ml) or for 6 hours with IL4 (50 ng/ml) before lysis with TRIzol®. RNA was prepared using the Qiagen 
Micro RNAeasy Kit following manufacturer’s instructions. cDNA preparation was done with the iScript cDNA 
Synthesis Kit (BioRad). Real time PCRs were performed on a BioRad CFX-96 Cycler using its software for analy-
sis. Primer pairs used were IL 10 (fw: 5′- TTT GAA TTC CCT GGG TGA GAA – 3′, rv: 5′- CTC CAC TGC CTT 
GCT CTT ATT TTC - 3′), IFNγ (fw: 5′- ATC TGG AGG AAC TGG CAA AA - 3′, rv: 5′- TTC AAG ACT TCA 
AAG AGT CTG AGG TA - 3′), IL6 (fw: 5′- CTG CAA GAG ACT TCC ATC CAG TT - 3′, rv: 5 ‘- GAA GTA GGG 
AAG GCC GTG G - 3′), TNFα (fw: 5′- CAT CTT CTC AAA ATT CGA GTG ACA A – 3′, rv: 5′- TGG GAG TAG 
ACA AGG TAC AAC CC - 3′), Mannose Receptor (fw: 5′-TGC CAA AAA TTA TTG ATC CTG TAA CT - 3′, 
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rv: 5′- CGC CGG CAC CTA TCA CA - 3′), Fizz1 (fw: 5′- CTG CCC TGC TGG GAT GAC - 3′, rv: 5′- TCC ACT 
CTG GAT CTC CCA AGA - 3′) and YM1 (fw: 5′- TGG CCC ACC AGG AAA GTA CA - 3′, rv: 5′- CAG TGG 
CTC CTT CAT TCA GAA A - 3′). GAPDH (fw: 5′- CAA CTC ACT CAA GAT TGT CAG CAA – 3′, rv: 5′ - TGG 
CAG TGA TGG CAT GGA – 3′) was used as housekeeping gene.
Efferocytosis assay. Jurkat T were rendered apoptotic by exposure to UV-B light, labeled with home-made 
Annexin-V-pHrodo Green (2,5 ng/ml) and fed in a 3:1 ratio to Hoechst-labeled BMDMs derived from sorted 
bone marrow as described above. After 45 min, BMDMs were washed and imaged using a BD Pathway 855 
High-Content Imager with a 10x magnification. Image analysis was done using Attovision Software and image 
data was further processed using DIVA software.
Statistical analysis. All data is presented as mean ± SEM. Data was processed using GraphPad Prism 5 
(Graph Pad Software Inc., San Diego, CA, USA). Individual groups of normally distributed data were analyzed 
with a Student’s t-test, otherwise a non-parametric Mann-Whitney U test was used. Data containing more than 
two groups was analyzed with 1-way ANOVA (when showing a Gaussian distribution) or the non-parametric 
Kruskal-Wallis test, and results were corrected for multiple testing. Differences were considered significant if 
p < 0.05 (denoted as *p < 0.05, **p < 0.01, ***p < 0.001).
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